Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

Imagem de Miniatura
Arquivos
art_FRAGA_Adverse_events_of_nucleostide_analogues_for_chronic_hepatitis_2020.PDF (579.1 KB)
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER JAPAN KK
Autores
Citação
JOURNAL OF GASTROENTEROLOGY, v.55, n.5, p.496-514, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a small risk of any of these toxicities can represent a major medical issue. The main objective of this review was to analyse information available on AEs associated with the use of NAs in published studies. We choose the following MesH terms for this systematic review: chronic hepatitis B, side effects and treatment. All articles published from 1 January 1990 up to 19 February 2018 in MEDLINE of PubMed, EMBASE, the Cochrane Library and LILACS databases were searched. A total of 120 articles were selected for analysis, comprising 6419 patients treated with lamivudine (LAM), 5947 with entecavir (ETV), 3566 with tenofovir disoproxil fumarate (TDF), 3096 with telbivudine (LdT), 1178 with adefovir dipivoxil (ADV) and 876 with tenofovir alafenamide (TAF). The most common AEs in all NAs assessed were abdominal pain/discomfort, nasopharyngitis/upper respiratory tract infections, fatigue, and headache. TAF displays the highest density of AEs per patient treated among NAs (1.14 AE/treated patient). In conclusion, treatment of CHB with NAs is safe, with a low incidence of AEs. Despite the general understanding TAF being safer than TDF, the number of patients treated with TAF still is too small in comparison to other NAs to consolidate an accurate safety profile. PROSPERO Registration No. CRD42018086471
Palavras-chave
Chronic hepatitis B, Nucleotide, nucleoside analogues, Adverse events
URI
https://observatorio.fm.usp.br/handle/OPI/35962
Referências
  1. Agarwal K, 2015, J HEPATOL, V62, P533, DOI 10.1016/j.jhep.2014.10.035
  2. Ahn J, 2016, ALIMENT PHARM THER, V43, P134, DOI 10.1111/apt.13440
  3. Ahn SS, 2014, CLIN MOL HEPATOL, V20, P261, DOI 10.3350/cmh.2014.20.3.261
  4. Al Ashgar H, 2017, SAUDI J GASTROENTERO, V23, P190, DOI 10.4103/sjg.SJG_541_16
  5. Ali HY, 2003, SAUDI MED J, V24, P996
  6. Alsohaibani F, 2015, SAUDI J GASTROENTERO, V21, P295, DOI 10.4103/1319-3767.164189
  7. An J, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0572-2
  8. Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae
  9. Berg T, 2014, J HEPATOL, V60, P715, DOI 10.1016/j.jhep.2013.11.024
  10. Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053
  11. Booth A, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-2
  12. Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30107-8, 10.1016/S2468-1253(16)30020-6]
  13. Buti M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7
  14. Buti M, 2012, EUR J GASTROEN HEPAT, V24, P535, DOI 10.1097/MEG.0b013e3283511287
  15. Chan HLY, 2007, ANN INTERN MED, V147, P745, DOI 10.7326/0003-4819-147-11-200712040-00183
  16. Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3
  17. Chan HLY, 2014, GASTROENTEROLOGY, V146, P1240, DOI 10.1053/j.gastro.2014.01.044
  18. Chan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006
  19. Chang TT, 2009, J VIRAL HEPATITIS, V16, P784, DOI 10.1111/j.1365-2893.2009.01142.x
  20. Chang TT, 2005, GASTROENTEROLOGY, V129, P1198, DOI 10.1053/j.gastro.2005.06.055
  21. Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285
  22. Chien RN, 2014, J GASTROEN HEPATOL, V29, P185, DOI 10.1111/jgh.12416
  23. Da Silva LC, 2001, J GASTROENTEROL, V36, P476, DOI 10.1007/s005350170071
  24. de Man RA, 2001, HEPATOLOGY, V34, P578, DOI 10.1053/jhep.2001.26815
  25. Dienstag JL, 2003, HEPATOLOGY, V37, P748, DOI 10.1053/jhep.2003.50117
  26. DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501
  27. Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702
  28. Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013
  29. Du Jeong In, 2017, Dig Dis Sci, V62, P2908, DOI 10.1007/s10620-017-4737-1
  30. Du QW, 2013, MED SCI MONITOR, V19, P751, DOI 10.12659/MSM.889443
  31. European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021
  32. Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885
  33. Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388
  34. Fung S, 2017, J HEPATOL, V66, P11, DOI 10.1016/j.jhep.2016.08.008
  35. Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028
  36. Gane EJ, 2011, LIVER INT, V31, P676, DOI 10.1111/j.1478-3231.2011.02490.x
  37. Gill US, 2015, J INFECT DIS, V211, P374, DOI 10.1093/infdis/jiu471
  38. Gilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.x
  39. Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025
  40. Gotham D, 2017, CURR OPIN HIV AIDS, V12, P324, DOI 10.1097/COH.0000000000000379
  41. Guo XH, 2018, INT J ANTIMICROB AG, V52, P201, DOI 10.1016/j.ijantimicag.2018.04.002
  42. Gwak GY, 2013, HEPATOL INT, V7, P106, DOI 10.1007/s12072-012-9368-1
  43. Hadziyannis SJ, 2000, HEPATOLOGY, V32, P847, DOI 10.1053/jhep.2000.17915
  44. Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020
  45. Heo J, 2012, ANTIVIR THER, V17, P1563, DOI 10.3851/IMP2277
  46. Hill A, 2018, J VIRUS ERAD, V4, P72
  47. Hongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318
  48. Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180
  49. Hou JL, 2015, J VIRAL HEPATITIS, V22, P85, DOI 10.1111/jvh.12313
  50. Hou JL, 2013, J VIRAL HEPATITIS, V20, P811, DOI 10.1111/jvh.12115
  51. Hou JL, 2015, ADV THER, V32, P727, DOI 10.1007/s12325-015-0232-2
  52. Hou JL, 2008, HEPATOLOGY, V47, P447, DOI 10.1002/hep.22075
  53. Huang MX, 2016, CLIN DRUG INVEST, V36, P471, DOI 10.1007/s40261-016-0392-0
  54. Huang MX, 2015, INT J CLIN EXP MED, V8, P666
  55. Imaz A, 2017, EXPERT REV ANTI-INFE, V15, P195, DOI 10.1080/14787210.2017.1286736
  56. Jia HY, 2015, ANN HEPATOL, V14, P175, DOI 10.1016/S1665-2681(19)30779-3
  57. Jia JD, 2014, HEPATOL INT, V8, P72, DOI 10.1007/s12072-013-9488-2
  58. Kamezaki H, 2011, SCAND J GASTROENTERO, V46, P1111, DOI 10.3109/00365521.2011.584898
  59. Karino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-x
  60. Kayaaslan B, 2017, WORLD J HEPATOL, V9, P227, DOI 10.4254/wjh.v9.i5.227
  61. Kim HR, 2015, LIVER INT, V35, P860, DOI 10.1111/liv.12605
  62. Kim HJ, 2010, J GASTROEN HEPATOL, V25, P1374, DOI 10.1111/j.1440-1746.2010.06381.x
  63. Kim HJ, 2010, LIVER INT, V30, P834, DOI 10.1111/j.1478-3231.2010.02245.x
  64. Kim HJ, 2015, KOREAN J INTERN MED, V30, P32, DOI 10.3904/kjim.2015.30.1.32
  65. Kobashi H, 2009, J GASTROEN HEPATOL, V24, P255, DOI 10.1111/j.1440-1746.2008.05593.x
  66. Koike K, 2018, HEPATOL RES, V48, P59, DOI 10.1111/hepr.12902
  67. Kwon YJ, 2015, NIGER J CLIN PRACT, V18, P796, DOI 10.4103/1119-3077.163296
  68. Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422
  69. Lai CL, 2014, GUT, V63, P996, DOI 10.1136/gutjnl-2013-305138
  70. Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201
  71. Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058
  72. Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287
  73. Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI [10.1053/j.gastro.2005.05.053, 10.1016/j.gastro.2005.05.053]
  74. Lai CL, 2002, J MED VIROL, V67, P334, DOI 10.1002/jmv.10075
  75. Lai CL, 1997, HEPATOLOGY, V25, P241, DOI 10.1002/hep.510250144
  76. Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470
  77. Lee KS, 2017, CLIN MOL HEPATOL, V23, P331, DOI 10.3350/cmh.2016.0040
  78. Leung NWY, 2014, INFECT DIS THER, V3, P191, DOI 10.1007/s40121-014-0039-5
  79. Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084
  80. Li XJ, 2013, CLIN THER, V35, P1546, DOI 10.1016/j.clinthera.2013.07.431
  81. Li Y, 2013, J VIRAL HEPATITIS, V20, P46, DOI 10.1111/jvh.12063
  82. Lian JS, 2013, WORLD J GASTROENTERO, V19, P6278, DOI 10.3748/wjg.v19.i37.6278
  83. Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559
  84. Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364
  85. Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026
  86. Lim SG, 2007, ALIMENT PHARM THERAP, V26, P1419, DOI 10.1111/j.1365-2036.2007.03506.x
  87. Lim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435
  88. Lo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724
  89. Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037
  90. Lok ASF, 2016, HEPATOLOGY, V63, P284, DOI 10.1002/hep.28280
  91. Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190
  92. Lu DTY, 2000, HEPATOLOGY, V32, P828, DOI 10.1053/jhep.2000.17912
  93. Lu JJ, 2013, J VIRAL HEPATITIS, V20, P40, DOI 10.1111/jvh.12062
  94. Luo J, 2013, INT J MED SCI, V10, P427, DOI 10.7150/ijms.5472
  95. Luo XD, 2017, J VIRAL HEPATITIS, V24, P36, DOI 10.1111/jvh.12790
  96. Mak LY, 2016, EXPERT OPIN DRUG SAF, V15, P383, DOI 10.1517/14740338.2016.1139573
  97. Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431
  98. Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681
  99. Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878
  100. Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414
  101. Marcellin P, 2016, DIGEST DIS SCI, V61, P3072, DOI 10.1007/s10620-015-4027-8
  102. Marcellin P, 2016, GASTROENTEROLOGY, V150, P134, DOI 10.1053/j.gastro.2015.09.043
  103. Marcellin P, 2015, J HEPATOL, V62, P41, DOI 10.1016/j.jhep.2014.08.021
  104. Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
  105. MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
  106. Mascolo A, 2017, PHARMACOL RES, V123, P122, DOI 10.1016/j.phrs.2017.07.005
  107. Mazur Wlodzimierz, 2002, Med Sci Monit, V8, pCR257
  108. Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
  109. Montazeri G, 2001, IRAN J MED SCI, V26, P1
  110. Nevens F, 1997, GASTROENTEROLOGY, V113, P1258, DOI 10.1053/gast.1997.v113.pm9322520
  111. Ozaras R, 2014, EUR J GASTROEN HEPAT, V26, P774, DOI 10.1097/MEG.0000000000000099
  112. Pan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089789
  113. Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206
  114. Perrillo RP, 2011, HEPATOL INT, V5, P654, DOI 10.1007/s12072-010-9228-9
  115. Pol S, 2012, J VIRAL HEPATITIS, V19, P377, DOI 10.1111/j.1365-2893.2012.01602.x
  116. Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534
  117. Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009
  118. Ren FY, 2007, WORLD J GASTROENTERO, V13, P4264, DOI 10.3748/wjg.v13.i31.4264
  119. Ridruejo E, 2014, WORLD J GASTROENTERO, V20, P7169, DOI 10.3748/wjg.v20.i23.7169
  120. Rizzetto M, 2005, J HEPATOL, V42, P173, DOI 10.1016/j.jhep.2004.10.006
  121. Rodriguez M, 2017, WORLD J GASTROENTERO, V23, P7459, DOI 10.3748/wjg.v23.i41.7459
  122. Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45
  123. Safadi R, 2011, LIVER INT, V31, P667, DOI 10.1111/j.1478-3231.2010.02360.x
  124. Santantonio T, 2000, J HEPATOL, V32, P300, DOI 10.1016/S0168-8278(00)80076-8
  125. Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4
  126. Sarin SK, 2005, AM J GASTROENTEROL, V100, P2463, DOI 10.1111/j.1572-0241.2005.00247.x
  127. Schiff ER, 2003, J HEPATOL, V38, P818, DOI 10.1016/S0168-8278(03)00076-X
  128. Shen HJ, 2016, CELL PHYSIOL BIOCHEM, V40, P370, DOI 10.1159/000452552
  129. Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007
  130. Shin SR, 2011, HEPATOL INT, V5, P664, DOI 10.1007/s12072-010-9238-7
  131. Shindo M, 2009, HEPATOL INT, V3, P445, DOI 10.1007/s12072-009-9135-0
  132. Suh DJ, 2010, ANTIMICROB AGENTS CH, V54, P1242, DOI 10.1128/AAC.01163-09
  133. Sun J, 2014, HEPATOLOGY, V59, P1283, DOI 10.1002/hep.26885
  134. Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026
  135. Suzuki F, 2008, J GASTROEN HEPATOL, V23, P1320, DOI 10.1111/j.1440-1746.2008.05455.x
  136. Tada T, 2018, J GASTROENTEROL, V53, P1196, DOI 10.1007/s00535-018-1467-x
  137. Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321
  138. Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728
  139. Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156
  140. Vitoria M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20504
  141. Wang JC, 2013, EUR REV MED PHARMACO, V17, P1162
  142. Wang LC, 2011, HEPATOL INT, V5, P671, DOI 10.1007/s12072-010-9243-x
  143. Wang Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-388
  144. Wolters LMM, 2001, EUR J GASTROEN HEPAT, V13, P1499, DOI 10.1097/00042737-200112000-00016
  145. Wu IT, 2017, CLIN MICROBIOL INFEC, V23, P464, DOI 10.1016/j.cmi.2017.02.001
  146. Yang FQ, 2017, WORLD J GASTROENTERO, V23, P306, DOI 10.3748/wjg.v23.i2.306
  147. Yao FY, 2000, J HEPATOL, V33, P301, DOI 10.1016/S0168-8278(00)80371-2
  148. Yao GB, 2009, J DIG DIS, V10, P131, DOI 10.1111/j.1751-2980.2009.00375.x
  149. Yao Guang-Bi, 2004, Hepatobiliary Pancreat Dis Int, V3, P188
  150. Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036
  151. Yuen MF, 2015, J HEPATOL, V62, P526, DOI 10.1016/j.jhep.2014.10.026
  152. Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x
  153. Zhang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.024
  154. Zheng MH, 2010, CLIN THER, V32, P649, DOI 10.1016/j.clinthera.2010.04.001

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03